© Springer International Publishing Switzerland 2017
Paul M. N. Werker, Joseph Dias, Charles Eaton, Bert Reichert and Wolfgang Wach (eds.)Dupuytren Disease and Related Diseases – The Cutting Edge10.1007/978-3-319-32199-8_5757. International Clinical Research – The Australian Perspective: A Personal View
(1)
Brisbane Hand and Upper Limb Clinic, 259 Wickham Tce., Brisbane, QLD, 4000, Australia
Keywords
Clinical researchAustraliaSurgeryCollagenase57.1 Introduction
Australia is a long way from everywhere, which makes large database research difficult. Australia has a population of approximately 25 million, and as the country was populated by European migration around 200 years ago, the majority of the current population is of European ancestry. There is thus a high incidence of Dupuytren Disease. The nearest continents to Australia are Asia and Antarctica, neither of which has a very high incidence of Dupuytren patients within them. In order to conduct any research of significance into Dupuytren Disease it will require an association with larger population groups.
In 2006, offers were made from Auxilium Pharmaceuticals to participate in multicentre international trials on research with collagenase treatment for Dupuytren Disease. I have continued with Dupuytren Disease research since that time.
57.2 Advantages and Disadvantages
To participate in any international study will depend on the study group and the population to be investigated. One needs to select the population group carefully. For example, Dupuytren Disease is rare in Asia, so that population group may not be suitable. Melanoma is common in tropical Australia, but much rarer in a northern European nation. If an association with an international group or country is to be considered, the relative incidence of the disease to be investigated should be considered.
With international involvement, case numbers multiply, enabling a large series to be investigated. For example, in one multinational study over a 5-year period, it was possible to follow up 950 Dupuytren subjects injected with collagenase in 1081 treated joints.
By working in differing countries, a variation in population subjects can be expected. This may reduce genetic/country/external influences and give a more balanced population study group. The cost can be spread by working in differing countries. Industries, research foundations and charities have different rules in varying countries which may allow more opportunities.
The type of research study needs to be carefully considered. Data collection is relatively straightforward, but tissue collection may be difficult if it requires transfer from one country to another, especially if refrigeration/liquid nitrogen is required. The cost may become prohibitive. Blood, urine or tissue samples are difficult to transport internationally. There is a risk of sample loss over such large distances. Customs may block the import of human tissues or fluids and needs to be confirmed before international transfers. Monitoring of surgical techniques may not be comparable between countries.
A major advantage of the digital age is that it has made the world smaller. Although Australia is on the opposite side of the world to Europe and the Americas, it is readily accessible via the Internet. Facilities such as Skype may allow videoconferencing, and electronic case report forms (eCRF) make transfer of information and data simpler and instant. Teleconferencing is a possibility, although additional costs may result.